Stay updated on Empagliflozin Effect on Tissue Sodium in Heart Failure Clinical Trial

Sign up to get notified when there's something new on the Empagliflozin Effect on Tissue Sodium in Heart Failure Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Empagliflozin Effect on Tissue Sodium in Heart Failure Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.0 and previous revision v3.4.3 removed. This reflects a backend update to the page's versioning rather than changes to study data.
    Difference
    0.1%
    Check dated 2026-03-19T23:48:15.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T20:39:40.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Added the final published reference (Eur J Heart Fail, 2025) and removed the online-ahead-of-print citation for the study publications section.
    Difference
    0.1%
    Check dated 2026-02-26T10:13:09.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The long notice about government funding lapses and the previous Revision: v3.4.1 entry were removed.
    Difference
    0.5%
    Check dated 2026-02-12T02:01:58.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status was added, including links to cc.nih.gov and opm.gov. The page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T12:34:26.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    Added a glossary display option and a new QC-related label ('Last Update Submitted that Met QC Criteria'), updated FEAR Act labeling, and bumped the revision to v3.4.0. The previous QC label capitalization and version 3.3.4 were removed.
    Difference
    0.2%
    Check dated 2026-01-28T10:00:18.000Z thumbnail image

Stay in the know with updates to Empagliflozin Effect on Tissue Sodium in Heart Failure Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Empagliflozin Effect on Tissue Sodium in Heart Failure Clinical Trial page.